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Among the five genetically distinct hantaviruses (family *Bunyaviridae*, genus *Hantavirus*) discovered hitherto in moles (order *Eulipotyphla*, family *Talpidae*) from Europe, Asia, and North America ([@B1]), only one, Rockport virus, which is harbored by the eastern mole (*Scalopus aquaticus*) in the United States ([@B2]), has been fully sequenced. A sequence alignment and comparison of Rockport virus and the partial genomes of other mole-borne hantaviruses indicate that Nova virus (NVAV), originally detected in archival liver tissue of a European mole (*Talpa europaea*) captured in Zala County, Hungary, in 1999 ([@B3]) and subsequently shown to be widespread in France ([@B4]) and Poland ([@B5]), appears to be the most divergent ([@B3][@B4][@B5]). However, the unavailability of the full-genome sequence of NVAV has impeded progress in ascertaining the evolutionary history of hantaviruses.

Here, we report the full-length genome sequence of NVAV strain Te34 (also known as strain 3483), isolated in Vero E6 cells (CRL 1586; American Type Culture Collection, Manassas, VA) from lung tissue of an adult male European mole, captured in Huta Dłutowska (51°35′49.51″N 19°22′46.80″E) near Łódź in central Poland on 26 August 2013. Total RNA, which was extracted from infected Vero E6 cells and original lung tissue using the PureLink Micro-to-Midi total RNA purification system (Invitrogen, San Diego, CA), was reverse transcribed using the SuperScript III first-strand synthesis systems (Invitrogen) with random hexamers. The negative-sense single-stranded tripartite RNA genome of NVAV was amplified using oligonucleotide primers designed with the MegAlign Clustal W program (DNAStar, Inc., Madison, WI). The 5′ and 3′ termini of each segment were amplified using the 3′-Full RACE core set (TaKaRa Bio, Inc., Otsu, Japan). For taxonomic verification of the mole host, the 1,140-nucleotide cytochrome *b* gene of mitochondrial DNA was amplified by PCR and sequenced ([@B3]).

The full-length L-genomic segment of NVAV strain Te34 was 6,563 nucleotides, with a predicted RNA-dependent RNA polymerase (RdRp) of 2,157 amino acids, starting at nucleotide position 34 and including 56 nucleotides of the 3′ noncoding region. The entire M-genomic segment of NVAV Te34 was 3,590 nucleotides, with a predicted glycoprotein precursor (GnGc) of 1,127 amino acids. The highly conserved WAASA amino acid motif of the M segment was found at amino acid positions 641 to 645. The full-length 1,825-nucleotide S-segment sequence of the NVAV isolate and the NVAV in the original lung tissue were identical, containing a single open reading frame with a predicted nucleocapsid (N) protein of 428 amino acids (nucleotide positions 53 to 1339), and 52- and 486-nucleotide 5′ and 3′ noncoding regions, respectively. A comparison of the S segments between the NVAV isolate and the prototype NVAV strain MSB95703 from Hungary showed nucleotide and amino acid sequence similarities of 85.6% and 96.5%, respectively. The secondary structure of the predicted N protein of NVAV strain Te34 was virtually identical to that reported earlier for the prototype NVAV strain ([@B3]).

Nucleotide sequence accession numbers. {#s1}
--------------------------------------

The GenBank accession numbers for the genome sequences of the NVAV Te34 isolate are [KR072621](KR072621), [KR072622](KR072622), and [KR072623](KR072623) for the S, M, and L segments, respectively. The GenBank accession number for the corresponding S segment from the original lung tissue is [KM403445](KM403445).
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